SAR443820
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2020 (NCT05795907)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05630547 | Phase 2 | Nov 30, 2022 | Sanofi |
| NCT05237284 | Phase 2 | Apr 13, 2022 | Sanofi |
| NCT05797753 | Phase 1 | Feb 18, 2022 | Sanofi |
| NCT04982991 | Phase 1 | Aug 5, 2021 | Sanofi |
| NCT05797701 | Phase 1 | Jul 28, 2021 | Sanofi |
| NCT05795907 | Phase 1 | Nov 30, 2020 | Sanofi |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sanofi | For profit | 6 | 6 | 2 | 2020 |
1 organizations
Page 1 / 1